Concepedia

RGS12 is a novel tumor suppressor in osteosarcoma that inhibits YAP-TEAD1-Ezrin signaling

Yang Li, Min Liu, Shuting Yang, Ashley M. Fuller, T.S. Karin Eisinger‐Mathason, Shuying Yang

Oncogene · 2021 · 37 citations · 39 references

DOIFull text

Open access

Concepts

References

39

Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling

Fa‐Xing Yu, Bin Zhao, Nattapon Panupinthu et al. · Cell · 2012 · 1.7K citations

, , +12

Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

Paul A. Meyers, Cindy L. Schwartz, Mark Krailo et al. · Journal of Clinical Oncology · 2005 · 719 citations · Full text

, , +15

The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis

Chand Khanna, Xiaolin Wan, Seuli Bose et al. · Nature Medicine · 2004 · 718 citations

, , +12

The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain

John M. Lamar, Patrick Stern, Hui Liu et al. · Proceedings of the National Academy of Sciences · 2012 · 686 citations · Full text

, , +17

PDZ domains and their binding partners: structure, specificity, and modification

Ho‐Jin Lee, Jie Zheng · Cell Communication and Signaling · 2010 · 584 citations · Full text

, , +17